The EPS projection of SurModics, Inc. (NASDAQ:SRDX) for quarter ended 2016-09-30 is $0.1. Last week, the EPS forecast was $0.1 against target of $0.1, a month earlier. Two months ago, this estimate was $0.1 versus forecast of $0.1 three months earlier, implying a deviation of 0%.
SurModics, Inc. (NASDAQ:SRDX) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 2.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for SurModics, Inc. (NASDAQ:SRDX) in the preceding 30, 120, 60 and 90 days were 0, 1, 1, and 1, correspondingly.
SurModics, Inc. (NASDAQ:SRDX) EPS target for the quarter closed 2 was $0.1, based on 2 recommendations. As reported on 2016-05-02 the EPS was $0.2. The change was $0.12, implying a percentage deviation of 150%. The projections showed a standard deviation of 0.03.
Quarterly Sales Estimates
SurModics, Inc. (NASDAQ:SRDX) yearly sales prediction for the fiscal 2016 stands at $16.718 and the median estimate is at $16.718. Almost 2 analysts issued sales target.
Highest sales target is $16.94 while the lowest target is $16.496 showing standard deviation of 0.313%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. SurModics, Inc. (NASDAQ:SRDX) announced that the deviation in forecast was -2.507%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...